34 results on '"Jian, Weiguo"'
Search Results
2. Supplementary Table 1 from Stat3 Activation in Urothelial Stem Cells Leads to Direct Progression to Invasive Bladder Cancer
3. Supplementary Figure 2 from Stat3 Activation in Urothelial Stem Cells Leads to Direct Progression to Invasive Bladder Cancer
4. Supplementary Figure 3 from Stat3 Activation in Urothelial Stem Cells Leads to Direct Progression to Invasive Bladder Cancer
5. Supplementary Figure 1 from Stat3 Activation in Urothelial Stem Cells Leads to Direct Progression to Invasive Bladder Cancer
6. Supplementary Figure 4 from Stat3 Activation in Urothelial Stem Cells Leads to Direct Progression to Invasive Bladder Cancer
7. Supplementary Figure Legends 1-4, Table Legend 1 from Stat3 Activation in Urothelial Stem Cells Leads to Direct Progression to Invasive Bladder Cancer
8. Chemoprevention of BBN-Induced Bladder Carcinogenesis by the Selective Estrogen Receptor Modulator Tamoxifen
9. Sunitinib malate is active against human urothelial carcinoma and enhances the activity of cisplatin in a preclinical model
10. Efficacy of Selective Estrogen Receptor Modulators in Nude Mice Bearing Human Transitional Cell Carcinoma
11. Comprehensive molecular characterization of urothelial bladder carcinoma
12. Urinary Levels of Soluble E-Cadherin in the Detection of Transitional Cell Carcinoma of the Urinary Bladder
13. ONE-YEAR OUTCOME OF BLADDER AUGMENTATION WITH A NOVEL BIODEGRADABLE MATRIX IN A PORCINE MODEL: 214
14. Expression of estrogen receptors-α and -β in bladder cancer cell lines and human bladder tumor tissue
15. Expression of estrogen receptors-[alpha] and -[beta] in bladder cancer cell lines and human bladder tumor tissue
16. Correlation of Cyclooxygenase-2 Expression With Molecular Markers, Pathological Features and Clinical Outcome of Transitional Cell Carcinoma of the Bladder
17. Positive association of collagen type I with non-muscle invasive bladder cancer progression
18. Activity of CEP-9722, a poly (ADP-ribose) polymerase inhibitor, in urothelial carcinoma correlates inversely with homologous recombination repair response to DNA damage
19. The preclinical anti-angiogenic and pro-apoptotic activity of lenalidomide in urothelial carcinoma (UC).
20. CEP-11981, a small molecule inhibitor of multiple angiogenic targets, in a preclinical system of urothelial carcinoma (UC).
21. A conventional preclinical schedule of cisplatin is more effective than a metronomic frequent bolus schedule for urothelial carcinoma
22. Stat3 Activation in Urothelial Stem Cells Leads to Direct Progression to Invasive Bladder Cancer
23. The preclinical activity of lenalidomide in urothelial carcinoma (UC).
24. Dasatinib Is Preclinically Active against Src-Overexpressing Human Transitional Cell Carcinoma of the Urothelium with Activated Src Signaling
25. Enzastaurin shows preclinical antitumor activity against human transitional cell carcinoma and enhances the activity of gemcitabine
26. 945. Combination Treatment of Adenovirus Mediated HSV-Thymidine Kinase Suicide Gene Therapy and Docetaxel in Bladder Cancer
27. 784: Therapeutic Effects of Combination Radiation and Suicide Gene Therapy Using a Chimeric Adenovirus Vector for Bladder Cancer
28. Role of Glycogen Synthase Kinase 3β in Rapamycin-Mediated Cell Cycle Regulation and Chemosensitivity
29. Targeting Mammalian Target of Rapamycin Synergistically Enhances Chemotherapy-Induced Cytotoxicity in Breast Cancer Cells
30. 946: A Chimeric Adenovirus Vector Enhaces Suicide Gene Therapy for Bladder Cancer
31. 735: Differential Expression of Estrogen Receptor α and β in Bladder Cancer Cell Lines and Human Bladder Tumor Tissue
32. Determinants of Rapamycin Sensitivity in Breast Cancer Cells
33. The preclinical activity of lenalidomide in indolent urothelial carcinoma.
34. The angiopoietin-TIE2 pathway is a potential therapeutic target in urothelial carcinoma.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.